Important stratifications for the treatment of ALL
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, Torsten Haferlach, MD, of MLL Munich Leukemia Laboratory, Munich, Germany, st...
Author: VJHemOnc
Added: 08/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Future therapies for AML: bispecifics and small molecule inhibitors
With the recent maturation of novel therapies for acute myeloid leukemia (AML), the field of AML therapeutics is rapidly progressing. In this interview, Farhad Ravandi, MD, from the University of Texa...
Author: VJHemOnc
Added: 08/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 16, 2018 Category: Cancer & Oncology Source Type: podcasts
ALL diagnostics: challenges and considerations
In this interview, Torsten Haferlach, MD, of MLL Munich Leukemia Laboratory, Munich, Germany, speaks about the difficulties in diagnosing and treating particular subsets of acute lymphoblastic leukemi...
Author: VJHemOnc
Added: 08/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 16, 2018 Category: Cancer & Oncology Source Type: podcasts
New CD22 CAR T-cells for pediatric R/R B-ALL is highly effective
Dr Jing Pan, of Beijing Boren Hospital, Beijing, P.R. China, discusses a new anti-CD22 CAR T-cell immunotherapy for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). Dr Pan ex...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
Bosutinib: a new, safer TKI for frontline CML
The recent FDA approval of bosutinib makes it the fourth inhibitor for the frontline treatment of chronic myeloid leukemia (CML), as Michael Mauro, MD, of Memorial Sloan Kettering Cancer Center, New Y...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
IDH inhibitors for AML and MDS
There has been an influx of novel therapies within the field of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Here, Eunice Wang, MD, of Roswell Park Comprehensive Cancer Center, Bu...
Author: VJHemOnc
Added: 08/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2018 Category: Cancer & Oncology Source Type: podcasts
How has MRD changed our ability to diagnose leukemia?
Measurable residual disease (MRD) testing is revolutionizing our ability to determine the disease state of a patient. In this video, Elizabeth Macintyre, MD, PhD, of the Hpital Necker-Enfants Malades...
Author: VJHemOnc
Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts
The ALL frontier: should T-ALL be classed as a different disease?
Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, Elizabeth Macintyre, MD, PhD, of the Hpital Necker-Enfants Malades, Paris, France, explains why she bel...
Author: VJHemOnc
Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts
Key points in patient support across hematological oncology
Felice Bombaci, from the AIL patient group for chronic myeloid leukemia (CML), Rome, Italy, discusses some important key topics in patient support in Italy for hematological malignancies. He speaks ab...
Author: VJHemOnc
Added: 08/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 13, 2018 Category: Cancer & Oncology Source Type: podcasts
Results of the COG AALL0434 trial for T-cell malignancies
Patients with T-cell leukemias typically have a worse prognosis than those with B-cell malignancies. In this interview, Kimberly Dunsmore, MD, from Virginia Tech Carilion School of Medicine, Roanoke, ...
Author: VJHemOnc
Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Venetoclax combination therapy in relapsed ALL
There is an unmet need for treatment options for acute lymphoblastic leukemia (ALL) patients who have relapsed on multiple prior therapies. Thomas Alexander, MD, PhD, of the University of North Caroli...
Author: VJHemOnc
Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Key points in patient support across hematological oncology
Felice Bombaci, from the AIL patient group for chronic myeloid leukemia (CML), Rome, Italy, discusses some important key topics in patient support in Italy for hematological malignancies. He speaks ab...
Author: VJHemOnc
Added: 08/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Understanding the evolution from haematopoietic stem cell to leukemic cell
Haematopoietic stem cells give rise to the multitude of blood cells in our circulatory system. In this video, Dominique Bonnet, PhD, of the Francis Crick Institute, London, UK, speaks to us about the ...
Author: VJHemOnc
Added: 08/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 8, 2018 Category: Cancer & Oncology Source Type: podcasts
Does TP53-mutated clonal size impact outcomes of CLL patients from the MURANO study?
The MURANO study (NCT02005471) is a Phase III trial looking at rituximab in combination with either bendamustine or venetoclax for the treatment of refractory chronic lymphocytic Leukemia (CLL). A key...
Author: VJHemOnc
Added: 08/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2018 Category: Cancer & Oncology Source Type: podcasts
The future of leukemia treatment leans towards immunotherapy
Chemotherapy is becoming increasingly less desirable as a form of treatment, due to its systemic and burdensome nature. Instead, immunotherapy has been dominating the field of treatment, with agents t...
Author: VJHemOnc
Added: 08/07/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 7, 2018 Category: Cancer & Oncology Source Type: podcasts
